Highlights Intervacc AB

Equities

IVACC

SE0009607252

Delayed Nasdaq Stockholm Other stock markets 06:01:56 2024-07-09 am EDT			5-day change	1st Jan Change
3.16 ^SEK	-2.47%		-0.63%	-50.08%

May. 15	Intervacc AB Announces Board Appointments	CI
May. 15	Intervacc AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Intervacc AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Intervacc AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 16	CI
Intervacc AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
Intervacc, Moredun Scientific Receive Eurostars Grant for Vaccine Against Pig Infection	Feb. 08	MT
Intervacc AB Awards Prestigious Eurostars Grant to Advance Their New Prototype Vaccine Against Streptococcus Suis Infection in Pigs	Feb. 07	CI
Intervacc Secures US Patent for Vaccine Against Infectious Disease Targeting Pigs	Nov. 23	MT
Intervacc AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16	CI
Intervacc AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-31	CI
Swedish Animals Vaccine Maker Intervacc Partners With Testa Center	23-07-11	MT
Intervacc to Collaborate with Testa Center to Optimise Production Processes for Their Prototype Vaccine for Pigs	23-07-11	CI
The European Medicines Agency Approves Extention of Shelf Life for Strangvac, Vaccine Against Equine Strangvac, to 33 Months	23-05-17	CI
Veterinary Medicines Directorate Extends the Shelf Life for Intervacc AB's Strangvac, a Vaccine Against Equine Strangvac, to 33 Months	23-05-08	CI
Intervacc AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-03	CI
Intervacc AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-17	CI
Intervacc AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-17	CI
Intervacc and the Swedish University of Agricultural Sciences, SLU, Extends Multi-Year Contract for the Development of Innovative Animal Health Vaccines	22-12-19	CI
Intervacc AB Announces Strangvac, A Vaccine Against Equine Strangles Released for Sales in Italy	22-12-13	CI
Intervacc AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Intervacc AB Announces First Batch of Strangvac for Sale in Germany, France, Austria, Belgium, Luxemburg and the Netherlands Released	22-10-12	CI
Intervacc AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Intervacc AB

Equities

IVACC

SE0009607252

Highlights

Filters